In contrast, Menin/KMT2A inhibition is effective in disrupting KMT2A dependent transcription in leukemia models that exhibit a dependency on KMT2A by preventing recruitment of the Menin/wild type KMT2A complex to a subset of target genes [41, 45]. Here, MEN1 is linked to leukemia.